TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Immutep completes patient enrolment for Phase II trial of eftilagimod alpha in metastatic breast cancer Immutep Limited, a clinical-stage biotechnology company specializing in advanced LAG-3 immunotherapies, has announced the completion of patient enrolment… byPallavi MadhirajuOctober 6, 2024